CARE CAPITAL INVESTMENTS II LP

CIK 00012230113 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001223011

Recent Transactions

34 trades

Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-19$2.08/sh−42,000→ 5,101,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-19$2.08/sh−42,000→ 5,101,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-19$2.08/sh−42,000→ 5,101,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-19$2.08/sh−42,000→ 5,101,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-18$2.13/sh−32,000→ 5,143,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-18$2.13/sh−32,000→ 5,143,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-18$2.13/sh−32,000→ 5,143,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-18$2.13/sh−32,000→ 5,143,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-17$2.15/sh−40,000→ 5,175,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-17$2.15/sh−40,000→ 5,175,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-17$2.15/sh−40,000→ 5,175,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-06-17$2.15/sh−40,000→ 5,175,114 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-20$2.39/sh−160,000→ 6,080,815 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-20$2.39/sh−160,000→ 6,080,815 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-20$2.39/sh−160,000→ 6,080,815 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-17$2.35/sh−350,000→ 6,240,815 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-17$2.35/sh−350,000→ 6,240,815 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2013-05-17$2.35/sh−350,000→ 6,240,815 total
Conversion
Anacor Pharmaceuticals, Inc.
Series E Preferred Stock
2010-11-30−107,004→ 0 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+1,348,313→ 1,348,313 total
Conversion
Anacor Pharmaceuticals, Inc.
Series C Preferred Stock
2010-11-30−1,348,313→ 0 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+102,787→ 1,451,100 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+107,004→ 1,558,104 total
Conversion
Anacor Pharmaceuticals, Inc.
Series D Preferred Stock
2010-11-30−102,787→ 0 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−305,375→ 2,169,104 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−305,375→ 2,169,104 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−20,950→ 148,776 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−305,375→ 2,169,104 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−305,375→ 2,169,104 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−20,950→ 148,776 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−20,950→ 148,776 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−20,950→ 148,776 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−305,375→ 2,169,104 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-11$26.40/sh−20,950→ 148,776 total

Companies

Recent Filings

Address

47 HULFISH STREET SUITE 310

PRINCETON, NJ, 08542

View on SEC.gov